RIC3 Protein — Acetylcholine Receptor Chaperone

📖 Wiki Page

protein1088 wordssynced 2026-04-02

RIC3 Protein — Acetylcholine Receptor Chaperone

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RIC3 Protein — Acetylcholine Receptor Chaperone</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>RIC3 (Chaperone Protein)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[RIC3](/genes/ric3)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9NWU8](https://www.uniprot.org/uniprot/Q9NWU8)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~30 kDa (271 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum (ER)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>RIC3 family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>RIC3, CHRNA7, AchR-associated protein</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (high), skeletal muscle, pancreas</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

RIC3 Protein — Acetylcholine Receptor Chaperone

Introduction

RIC3 (Resistant to Inhibitors of Cholinesterase 3) is a transmembrane chaperone protein localized primarily to the endoplasmic reticulum (ER) that is essential for the assembly and maturation of nicotinic acetylcholine receptors (nAChRs), particularly the [α7 nAChR](/proteins/alpha7-nachr) (CHRNA7). RIC3 facilitates proper folding, assembly, and surface expression of nAChRs through its ER-resident chaperone activity. In the nervous system, RIC3 plays critical roles in cholinergic signaling, synaptic plasticity, and cognitive function. Dysregulation of RIC3 has been implicated in [Alzheimer's Disease](/diseases/alzheimers-disease), [schizophrenia](/diseases/schizophrenia), [epilepsy](/diseases/epilepsy), and [ADD](/diseases/attention-deficit-disorder).

:: infobox .infobox-protein
::

Overview

RIC3 is an ER-resident chaperone protein that plays an essential role in nAChR biogenesis. Unlike classical molecular chaperones that primarily prevent aggregation, RIC3 specifically facilitates the folding and assembly of nAChR subunits into functional receptors.

The primary functions of RIC3 include:

Chaperone Function: RIC3 facilitates proper nAChR subunit folding and assembly

ER Quality Control: RIC3 helps export properly assembled receptors from the ER

Surface Expression: RIC3 is required for nAChR surface expression

Receptor Maturation: RIC3 promotes receptor maturation intermediates

The importance of RIC3 is most clearly demonstrated by studies showing that RIC3 knockdown dramatically reduces α7 nAChR surface expression, while RIC3 overexpression enhances it. This chaperone activity makes RIC3 essential for cholinergic signaling in the brain.

Structure

RIC3 is a 271-amino acid protein with a molecular weight of approximately 30 kDa. Key structural features include:

N-terminal ER Signal Sequence: Targets RIC3 to the ER
Transmembrane Domain: Single transmembrane helix anchors RIC3 in the ER membrane
Large Luminal Loop: The functional domain facing the ER lumen
C-terminal Cytoplasmic Tail: Small cytoplasmic domain
Coiled-coil Domains: Mediate subunit interactions

The structure of RIC3 is unique among chaperones, with its single transmembrane topology and relatively small size. The luminal loop contains the chaperone activity.

Normal Function

Chaperone Activity

RIC3 facilitates nAChR assembly through several mechanisms:

Subunit Recognition: RIC3 specifically recognizes nAChR subunit transmembrane domains

Assembly Promotion: RIC3 promotes subunit assembly into pentameric receptors

Folding Assistance: RIC3 helps correct folding intermediates

ER Export: RIC3 helps export assembled receptors from the ER

The chaperone activity is highly specific—RIC3 facilitates assembly of certain nAChR subtypes but not others.

α7 nAChR Assembly

RIC3 is particularly important for [α7 nAChR](/proteins/alpha7-nachr) assembly:

α7 Subunit Recognition: RIC3 specifically recognizes the α7 subunit

Pentamer Formation: RIC3 promotes formation of α7 homomeric receptors

Glycosylation: RIC3 affects receptor glycosylation

Trafficking: RIC3 enables ER-to-Golgi transport

The α7 nAChR is the primary neuronal nAChR in the brain, making RIC3 essential for brain cholinergic signaling.

Nicotinic Signaling

RIC3 enables cholinergic signaling through nAChRs:

Receptor Surface Expression: Without RIC3, nAChRs don't reach the surface

Calcium Signaling: α7 nAChR-mediated calcium influx requires RIC3

Synaptic Transmission: Cholinergic synaptic transmission requires RIC3

Neuromuscular Junction: RIC3 is essential for neuromuscular nAChRs

Brain Cholinergic System

In the brain, RIC3 supports cholinergic signaling:

Basal Forebrain: Cholinergic neurons require RIC3

Hippocampus: RIC3 in hippocampal interneurons

Cortex: Cortical cholinergic signaling

Attention: RIC3 supports attention circuits

Role in Disease

Alzheimer's Disease

RIC3 dysfunction contributes to AD through cholinergic deficits:

α7 nAChR Downregulation: AD brain shows reduced α7 nAChR

Cholinergic Degeneration: Basal forebrain cholinergic neurons degenerate early in AD

Amyloid-β Binding: Amyloid-β binds α7 nAChR, affecting signaling

Memory: Cholinergic signaling is essential for memory

The "cholinergic hypothesis" of AD posits that cholinergic deficit is a primary cause of cognitive decline. RIC3 supports this pathway.

Schizophrenia

RIC3 has been genetically and functionally implicated in [schizophrenia](/diseases/schizophrenia):

α7 nAChR Deficits: Schizophrenia is associated with α7 nAChR deficits

Sensory Gating: α7 nAChR is essential for sensory gating

P50 Gating: RIC3 affects P50 auditory gating deficits

Cognitive Deficits: RIC3 may affect cognitive symptoms

Nicotinic agonists are being developed for schizophrenia treatment.

Epilepsy

RIC3 affects neuronal excitability:

nAChR Dysregulation: Altered nAChR affects excitability

Hyper excitability: RIC3 deficiency may cause hyperexcitability

Seizure Susceptibility: Altered cholinergic signaling affects seizures

Temporal Lobe Epilepsy: RIC3 changes in TLE

Attention Deficit Disorder

RIC3 has been implicated in [ADD/ADHD](/diseases/attention-deficit-disorder):

α7 nAChR: Attention requires α7 nAChR signaling

Nicotinic Drugs: Nicotinic agonists improve attention

Prefrontal Cortex: RIC3 in prefrontal circuits

Clinical Trials: Nicotinic trials in ADHD

Therapeutic Targeting

Current therapeutic strategies targeting RIC3 and related pathways include:

α7 nAChR Agonists: [PNU-282987](/proteins/pnu-282987), [ABT-107](/proteins/abt-107) enhance signaling

Positive Allosteric Modulators: [PNU-120596](/proteins/pnu-120596) enhances α7 nAChR function

Cholinesterase Inhibitors: [Donepezil](/proteins/donepezil), [Rivastigmine](/proteins/rivastigmine) increase acetylcholine

Gene Therapy: RIC3 gene delivery is theoretically possible

Interacting Proteins

RIC3 interacts with:

[CHRNA7 (α7 nAChR](/proteins/alpha7-nachr)) — Primary target
[CHRNA2](/proteins/chrna2-protein) — nAChR subunit
[CHRNA3](/proteins/chrna3-protein) — nAChR subunit
[CHRNB2](/proteins/chrnb2-protein) — nAChR subunit
[NAPB](/proteins/napb-protein) — SNARE protein
[CALMD1](/proteins/calmd1-protein) — Calcium-modulating cyclophilin ligand

Key Publications

[Ng et al., RIC3 and nAChR assembly (2007)](https://pubmed.ncbi.nlm.nih.gov/17652130/) — Assembly mechanisms

[Lansdell et al., Ric3 acetylcholine receptor maturation (2010)](https://pubmed.ncbi.nlm.nih.gov/20685566/) — Maturation

[Hernandez et al., RIC3 in AD cholinergic signaling (2013)](https://pubmed.ncbi.nlm.nih.gov/24040020/) — AD connection

[Zhang et al., RIC3 schizophrenia and sensory gating (2015)](https://pubmed.ncbi.nlm.nih.gov/25632045/) — Schizophrenia

[Wang et al., RIC3 and alpha7 nAChR trafficking (2018)](https://pubmed.ncbi.nlm.nih.gov/29526538/) — Trafficking

[Castello et al., RIC3 variants in neurological disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32873908/) — Variants

Cross-Links

[RIC3 Gene](/genes/ric3) — Gene page
[α7 nAChR](/proteins/alpha7-nachr) — Receptor protein
[Cholinergic Signaling](/mechanisms/cholinergic-signaling-neurodegeneration) — Mechanism page
[Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page
[Schizophrenia](/diseases/schizophrenia) — Disease page
[Epilepsy](/diseases/epilepsy) — Disease page

References

[Ng et al., RIC3 and nAChR assembly (2007)](https://pubmed.ncbi.nlm.nih.gov/17652130/)

[Lansdell et al., Ric3 acetylcholine receptor maturation (2010)](https://pubmed.ncbi.nlm.nih.gov/20685566/)

[Hernandez et al., RIC3 in AD cholinergic signaling (2013)](https://pubmed.ncbi.nlm.nih.gov/24040020/)

[Zhang et al., RIC3 schizophrenia and sensory gating (2015)](https://pubmed.ncbi.nlm.nih.gov/25632045/)

[Wang et al., RIC3 and alpha7 nAChR trafficking (2018)](https://pubmed.ncbi.nlm.nih.gov/29526538/)

[Castello et al., RIC3 variants in neurological disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32873908/)

📖 View canonical wiki page →

RIC3 Protein — Acetylcholine Receptor Chaperone

RIC3 Protein — Acetylcholine Receptor Chaperone

Introduction

RIC3 Protein — Acetylcholine Receptor Chaperone

Introduction

Overview

Structure

Normal Function

Chaperone Activity

α7 nAChR Assembly

Nicotinic Signaling

Brain Cholinergic System

Role in Disease

Alzheimer's Disease

Schizophrenia

Epilepsy

Attention Deficit Disorder

Therapeutic Targeting

Interacting Proteins

Key Publications

Cross-Links

See Also

References